InTandem Capital Partners
Overview
InTandem Capital Partners is a private equity firm that invests in and helps accelerate the growth of small to mid-sized companies in select healthcare services sectors across North America. The firm makes control investments in payor, provider, and pharmaceutical services businesses, targeting companies with a starting point between $5 million and $30 million of EBITDA. InTandem employs an operationally intensive, hands-on approach and aligns its investment strategy with the Healthcare Quintuple Aim: enhanced patient experience, elevated provider experience, improved clinical outcomes, greater healthcare equity, and lower cost of care.
Portfolio Companies
12
Website
intandemcapital.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Atlas Health | Oct 2026 | Private Equity | Lead |
| beBright | Jun 2023 | Private Equity | Lead |
For institutional investors. Book with your work email.
Key People
John Courtney
Operating Partner
Aaron Newman
Principal
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is InTandem Capital Partners based?
InTandem Capital Partners is headquartered in New York City, New York, United States.
When was InTandem Capital Partners founded?
Founding year information for InTandem Capital Partners is not publicly available.
How many portfolio companies does InTandem Capital Partners have?
InTandem Capital Partners has 12 portfolio companies in Caplight's dataset.
What are some companies in InTandem Capital Partners's portfolio?
Portfolio companies visible on Caplight include Atlas Health, beBright.
What was InTandem Capital Partners's most recent investment shown here?
InTandem Capital Partners's most recent investment in this portfolio sample was in Atlas Health in 2026.
What sectors does InTandem Capital Partners focus on?
InTandem Capital Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Enterprise Software, Enterprise Software, Enterprise Software.
What company stages does InTandem Capital Partners focus on?
InTandem Capital Partners typically invests at the Late stage.
What is InTandem Capital Partners's AUM?
InTandem Capital Partners's assets under management are estimated between $2.6B and $2.6B.